Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin cancer caused hair loss and spread, needing multiple treatments.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

A woman's hair loss and scalp swelling, caused by a fungal infection, was wrongly treated but eventually cured with Terbinafine, emphasizing its effectiveness.

Different types of hair loss require specific treatments, and new treatments are being developed.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

A woman developed skin irritation from treatments for hair loss, showing allergies to both minoxidil and saw palmetto solutions.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

The woman's widespread skin condition did not improve despite various treatments.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Prolactin may affect hair growth differently based on gender and scalp area.

The document outlines a method for diagnosing hair loss and suggests specific treatments based on the diagnosis.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

A 4-year-old girl was diagnosed with erythrokeratodermia variabilis after other treatments failed.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.